Gray-Market Peptide Trade Exceeds $100M Annual Run Rate, Chainalysis Says
According to a report by Chainalysis, the crypto-powered gray-market peptide trade has surpassed a $100 million annual run rate, processing over $100 million annually primarily through Bitcoin and stablecoin payments. Crypto flows to peptide vendors surged 159% from $12 million in Q4 2025 to $32 million in Q1 2026, with Q2 2026 projected at $39 million. The growth is driven by the 'looksmaxxing' social media trend focused on physical appearance, as well as demand for cheaper alternatives to weight-loss drugs like Ozempic and Wegovy. Unlike early black markets such as Silk Road, this gray market gained popularity during the Make America Healthy Again movement and alternative health trends. Many vendors use Bitcoin and stablecoins due to banking restrictions on unapproved pharmaceutical compounds, with larger operators favoring stablecoins to hedge against crypto volatility. Chainalysis also identified Chinese chemical manufacturers previously involved in drug precursor sales, such as Shanghai Sigma Audley and Bigreat Technology, now supplying peptides. Senior Intelligence Analyst Sara Graham noted that influencers and public personalities are driving hundreds of thousands of first-time crypto buyers to this ecosystem.
Key facts
- Peptide gray market exceeds $100M annual run rate, using Bitcoin and stablecoins.
- Crypto flows to peptide vendors surged 159% from Q4 2025 to Q1 2026.
- Growth driven by 'looksmaxxing' trend and demand for weight-loss drug alternatives.
- Larger vendors prefer stablecoins to avoid crypto volatility.
- Some Chinese chemical manufacturers previously in drug precursors now supply peptides.